A collection of studies presented at a recent American Heart Association (AHA) conference has confirmed the heart health benefits provided by the new anti-obesity drugs, semaglutide and tirzepatide, ...
Jean Adams, Professor of Dietary Public Health at the University of Cambridge’s MRC Epidemiology Unit and Martin White, Professor of Population Health Research at the University of Cambridge’s MRC ...
As rates of obesity, as defined by body mass index (BMI), continue to climb in the United States, so have efforts to lose weight, including a new era of weight-loss drugs. Yet a new systematic review ...